Pharmaceuticals

Pharmaceuticals Biotechnology Venture Capital Obesity Vaccine Technology Contract Manufacturing Revenue Models Market Performance Spin-offs Investor Relations

5 ARTICLES

2w ago

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

The restructuring aims to sharpen strategic focus, address client concerns, and enhance shareholder value with a clear timeline for completion by October 2025.

3 ARTICLES

3w ago

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

3 ARTICLES

last mo.

Lotte Biologics Secures First ADC Manufacturing Deal, Launches Full-Scale Operations

3 ARTICLES

4mo ago

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development